Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Clonal hematopoiesis of indeterminate potential (CHIP), which is defined as the presence of an expanded somatic blood-cell clone in persons without other hematologic abnormalities, is common among older persons and is associated with an increased risk of hematologic cancer. We previously found preliminary evidence for an association between CHIP and atherosclerotic cardiovascular disease, but the nature of this association was unclear. METHODS: We used whole-exome sequencing to detect the presence of CHIP in peripheral-blood cells and associated such presence with coronary heart disease using samples from four case-control studies that together enrolled 4726 participants with coronary heart disease and 3529 controls. To assess causality, we perturbed the function of Tet2, the second most commonly mutated gene linked to clonal hematopoiesis, in the hematopoietic cells of atherosclerosis-prone mice. RESULTS: In nested case-control analyses from two prospective cohorts, carriers of CHIP had a risk of coronary heart disease that was 1.9 times as great as in noncarriers (95% confidence interval [CI], 1.4 to 2.7). In two retrospective case-control cohorts for the evaluation of early-onset myocardial infarction, participants with CHIP had a risk of myocardial infarction that was 4.0 times as great as in noncarriers (95% CI, 2.4 to 6.7). Mutations in DNMT3A, TET2, ASXL1, and JAK2 were each individually associated with coronary heart disease. CHIP carriers with these mutations also had increased coronary-artery calcification, a marker of coronary atherosclerosis burden. Hypercholesterolemia-prone mice that were engrafted with bone marrow obtained from homozygous or heterozygous Tet2 knockout mice had larger atherosclerotic lesions in the aortic root and aorta than did mice that had received control bone marrow. Analyses of macrophages from Tet2 knockout mice showed elevated expression of several chemokine and cytokine genes that contribute to atherosclerosis. CONCLUSIONS: The presence of CHIP in peripheral-blood cells was associated with nearly a doubling in the risk of coronary heart disease in humans and with accelerated atherosclerosis in mice. (Funded by the National Institutes of Health and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“That subjects with clonal hematopoiesis are more susceptible to develop nonhematological, most notably cardiovascular, disease”
From Aging of hematopoietic stem cells (2018) · cites this paper as [84]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These findings are supported by recent findings demonstrating a causal link between mutations in HSPCs in the context of clonal hematopoiesis with indeterminate origin and altered transcriptional output of macrophages, which affect the vascular wall and contributes to atherosclerosis.83,84”
From Inflammatory bone marrow microenvironment (2019) · cites this paper as [83]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As CHIP-associated mutations are known to alter the development and function of myeloid cells”
From Clonal hematopoiesis is associated with protection from Alzheimer’s disease (2023) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Tet2 and Ppm1d mutant murine models have demonstrated an increased inflammatory signature in mutant macrophages, with heightened inflammatory cytokine production upon pro-inflammatory stimulation in vitro [31,32,69,70].”
From Clonal hematopoiesis and inflammation – the perpetual cycle (2023) · cites this paper as [32]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Elevated IL-8 and IL-1β levels have been reported in patients with TET2 CH in the Pakistan Risk of Myocardial Infarction Study (PROMIS) [20,32]”
From Clonal hematopoiesis and inflammation – the perpetual cycle (2023) · cites this paper as [32]
Experimental — accuracy not yet measured
38 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Self-citationClonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Self-citationMacrophages in atherosclerosis: a dynamic balance
Moore, K. J., Sheedy, F. J., & Fisher, E. A. (2013) · Nature reviews. Immunology · doi:10.1038/nri3520 · Cited by 2,559
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
Steensma, D. P., Bejar, R., Jaiswal, S., Lindsley, R. C., Sekeres, M. A., Hasserjian, R. P., & Ebert, B. L. (2015) · Blood · doi:10.1182/blood-2015-03-631747 · Cited by 1,971
Self-citationAge-related mutations associated with clonal hematopoietic expansion and malignancies
Xie, M., Lu, C., Wang, J., McLellan, M. D., Johnson, K. J., Wendl, M. C., McMichael, J. F., Schmidt, H. K., Yellapantula, V., Miller, C. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3733 · Cited by 1,874
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
Fuster, J. J., MacLauchlan, S., Zuriaga, M. A., Polackal, M. N., Ostriker, A. C., Chakraborty, R., Wu, C.-L., Sano, S., Muralidharan, S., Rius, C., et al. (2017) · Science · doi:10.1126/science.aag1381 · Cited by 1,536
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
Shlush, L. I., Zandi, S., Mitchell, A., Chen, W. C., Brandwein, J. M., Gupta, V., Kennedy, J. A., Schimmer, A. D., Schuh, A. C., Yee, K. W., et al. (2014) · Nature · doi:10.1038/nature13038 · Cited by 1,443
Ishibashi, S., Brown, M. S., Goldstein, J. L., Gerard, R. D., Hammer, R. E., & Herz, J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116663 · Cited by 1,354
Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation
Moran-Crusio, K., Reavie, L., Shih, A., Abdel-Wahab, O., Ndiaye-Lobry, D., Lobry, C., Figueroa, M. E., Vasanthakumar, A., Patel, J., Zhao, X., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.001 · Cited by 1,339
Cited by
Items 301–400 of 1,015
Wang, S., Hu, S., Luo, X., Bao, X., Li, J., Liu, M., Lv, Y., Zhao, C., Zeng, M., Chen, X., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103964 · Cited by 103
Bernstein, N., Spencer Chapman, M., Nyamondo, K., Chen, Z., Williams, N., Mitchell, E., Campbell, P. J., Cohen, R. L., & Nangalia, J. (2024) · Nature Genetics · doi:10.1038/s41588-024-01755-1 · Cited by 115
“…0.04, maxsecond-tumor 0.05, foxog 0.9, snvcluster50 2, snvcluster100 4, repeats 12), (4) indels with 10 or fewer reads supporting the alternate allele 17 , and (5) variants in the gene MUC , olfactory genes and genes with recurrent synonymous mutations due to high rates of false positivity 63,64 .”
InfluentialArends, C. M., Liman, T. G., Strzelecka, P. M., Kufner, A., Löwe, P., Huo, S., Stein, C. M., Piper, S. K., Tilgner, M., Sperber, P. S., et al. (2023) · Blood · doi:10.1182/blood.2022017661 · Cited by 99
Innate Immune Signaling and Its Role in Metabolic and Cardiovascular Diseases
Xu, M. M., Liu, P. P., & Li, H. (2018) · Physiological Reviews · doi:10.1152/physrev.00065.2017 · Cited by 107
Schunk, S. J., Kleber, M. E., März, W., Pang, S., Zewinger, S., Triem, S., Ege, P., Reichert, M., Krawczyk, M. J., Weber, S. N., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab107 · Cited by 106
The Impact of Inflammation-Induced Tumor Plasticity during Myeloid Transformation
Yeaton, A., Cayanan, G., Loghavi, S., Dolgalev, I., Leddin, E. M., Loo, C. E., Torabifard, H., Nicolet, D., Wang, J., Corrigan, K., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1146 · Cited by 94
Colchicine prevents accelerated atherosclerosis in TET2 -mutant clonal haematopoiesis
Zuriaga, M. A., Yu, Z., Matesanz, N., Truong, B. M. T., Ramos-Neble, B. L., Lopez, M., Uddin, M. M., Nakao, T., Niroula, A., Zorita, V., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae546 · Cited by 111
Self-citationThe pathobiology of neurovascular aging
Santisteban, M. M., & Iadecola, C. (2025) · Neuron · doi:10.1016/j.neuron.2024.12.014 · Cited by 111
Clonality in context: hematopoietic clones in their marrow environment
Cooper, J. N., & Young, N. S. (2017) · Blood · doi:10.1182/blood-2017-07-794362 · Cited by 87
New Insights from Studies of Clonal Hematopoiesis
Gibson, C. J., & Steensma, D. P. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3044 · Cited by 100
“However, more recent studies in both human cohorts and animal models have replicated these findings, suggesting that CHIP has a causal role in the development of cardiovascular disease of a similar magnitude to hypertension, and that this role is driven in large part by specific functional effects of the mutations fou…”
BackgroundInfluentialSelf-citationGrigoriou, M., Banos, A., Filia, A., Pavlidis, P., Giannouli, S., Karali, V., Nikolopoulos, D., Pieta, A., Bertsias, G. K., Verginis, P., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215782 · Cited by 104
Epigenetic Regulators as the Gatekeepers of Hematopoiesis
Rodrigues, C. P., Shvedunova, M., & Akhtar, A. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.09.015 · Cited by 105
Trained Immunity: Long-Term Adaptation in Innate Immune Responses
Tercan, H., Riksen, N. P., Joosten, L. A. B., Netea, M. G., & Bekkering, S. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314212 · Cited by 110
Oxidized Phospholipids Promote NETosis and Arterial Thrombosis in LNK(SH2B3) Deficiency
Dou, H., Kotini, A. G., Liu, W., Fidler, T., Endo‐Umeda, K., Sun, X., Olszewska, M., Xiao, T., Abramowicz, S., Yalçınkaya, M., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.056414 · Cited by 103
Self-citationLin, A. E., Bapat, A. C., Xiao, L., Niroula, A., Ye, J., Wong, W. J., Agrawal, M., Farady, C. J., Boettcher, A., Hergott, C. A., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.065597 · Cited by 107
“…that mice and humans with TET2 -mutant CHIP have elevated IL-6 and IL-1 β , which are key effectors of CHIP-mediated atherosclerosis and CVD. 3,15,22,59 52–54 We found that heightened susceptibility to AF in our mouse model depends on the Nlrp3 inflammasome, whose expression is markedly…”
InfluentialSelf-citationPremature Aging in Young Cancer Survivors
Armenian, S. H., Gibson, C. J., Rockne, R. C., & Ness, K. K. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djy229 · Cited by 92
Self-citationCardiovascular Disease in Myeloproliferative Neoplasms
Leiva, O., Hobbs, G. S., Ravid, K., & Libby, P. (2022) · JACC CardioOncology · doi:10.1016/j.jaccao.2022.04.002 · Cited by 110
Self-citationSanMiguel, J. M., Eudy, E., Loberg, M. A., Young, K. A., Mistry, J. J., Mujica, K. D., Schwartz, L. S., Stearns, T. M., Challen, G. A., & Trowbridge, J. J. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0086 · Cited by 97
McClatchy, J., Strogantsev, R., Wolfe, E., Lin, H. Y., Mohammadhosseini, M., Davis, B. A., Eden, C., Goldman, D., Fleming, W. H., Conley, P., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43697-y · Cited by 95
“IL1 β exposure promotes expansion and myeloid bias of Tet2 -KO cells with elevated proin fl ammatory Ly6c hi and reduced Ly6c lo monocytes/macrophages IL1 β is a potent pro-in fl ammatory cytokine elevated in human and murine TET2 loss-of-function mutations-mediated CH 15 – 17 .”
El-Khoury, H., Lee, D. J., Alberge, J.-B., Redd, R., Cea-Curry, C. J., Perry, J., Barr, H., Murphy, C., Sakrikar, D., Barnidge, D., et al. (2022) · The Lancet Haematology · doi:10.1016/s2352-3026(22)00069-2 · Cited by 94
Rotz, S. J., Bhatt, N. S., Hamilton, B. K., Duncan, C., Aljurf, M. D., Atsuta, Y., Beebe, K. L., Buchbinder, D. K., Burkhard, P., Carpenter, P. A., et al. (2024) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2023.12.001 · Cited by 110
Asnani, A. H., Moslehi, J. J., Adhikari, B. B., Baik, A. H., Beyer, A., de Boer, R. A., Ghigo, A., Grumbach, I. M., Jain, S. S., & Zhu, H. (2021) · Circulation Research · doi:10.1161/res.0000000000000473 · Cited by 100
Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias
Schuermans, A., Vlasschaert, C., Nauffal, V., Cho, S. M. J., Uddin, M. M., Nakao, T., Niroula, A., Klarqvist, M. D. R., Weeks, L. D., Lin, A. E., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad670 · Cited by 101
Self-citationUnidirectional association of clonal hematopoiesis with atherosclerosis development
Díez-Díez, M., Ramos-Neble, B. L., de la Barrera, J., Silla-Castro, J. C., Quintas, A., Vázquez, E., Rey-Martín, M. A., Izzi, B., Sánchez-García, L., García‐Lunar, I., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03213-1 · Cited by 105
Self-citationBlockade of IL-6 signaling alleviates atherosclerosis in Tet2-deficient clonal hematopoiesis
Liu, W., Yalcinkaya, M., Maestre, I. F., Olszewska, M., Ampomah, P. B., Heimlich, J. B., Wang, R., Vela, P. S., Xiao, T., Bick, A. G., et al. (2023) · Nature Cardiovascular Research · doi:10.1038/s44161-023-00281-3 · Cited by 93
Self-citationCellular barcoding to decipher clonal dynamics in disease
Sankaran, V. G., Weissman, J. S., & Zon, L. I. (2022) · Science · doi:10.1126/science.abm5874 · Cited by 93
Impact of constitutional TET2 haploinsufficiency on molecular and clinical phenotype in humans
Kaasinen, E., Kuismin, O., Rajamäki, K., Ristolainen, H., Aavikko, M., Kondelin, J., Saarinen, S., Berta, D. G., Katainen, R., Hirvonen, E. A. M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09198-7 · Cited by 92
Tocchetti, C. G., Ameri, P., de Boer, R. A., D’Alessandra, Y., Russo, M., Sorriento, D., Ciccarelli, M., Kiss, B., Bertrand, L., Dawson, D. K., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa222 · Cited by 100
Haring, B., Reiner, A. P., Liu, J., Tobias, D. K., Whitsel, E., Berger, J. S., Desai, P., Wassertheil‐Smoller, S., LaMonte, M. J., Hayden, K. M., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.018789 · Cited by 91
Self-citationDefining the clinical validity of genes reported to cause pulmonary arterial hypertension
Welch, C. L., Aldred, M. A., Balachandar, S., Dooijes, D., Eichstaedt, C. A., Gräf, S., Houweling, A. C., Machado, R. D., Pandya, D., Prapa, M., et al. (2023) · Genetics in Medicine · doi:10.1016/j.gim.2023.100925 · Cited by 98
Glucose metabolism controls disease-specific signatures of macrophage effector functions
Watanabe, R., Hilhorst, M. L., Zhang, H., Zeisbrich, M., Berry, G. J., Wallis, B. B., Harrison, D. G., Giacomini, J. C., Goronzy, J. J., & Weyand, C. M. (2018) · JCI Insight · doi:10.1172/jci.insight.123047 · Cited by 97
“The possibility of a bone marrow defect associated with the risk for atherosclerotic cardiovascular disease has been raised by recent studies reporting enrichment of clonal hematopoiesis of indeterminate potential (CHIP) carriers among CAD patients (37), emphasizing the potential mechanistic connection between clonal…”
Shallis, R. M., Wang, R., Davidoff, A. J., Ma, X., Podoltsev, N. A., & Zeidan, A. M. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100706 · Cited by 100
Clonal myelopoiesis promotes adverse outcomes in chronic kidney disease
Dawoud, A. A. Z., Gilbert, R. D., Tapper, W. J., & Cross, N. C. P. (2022) · Leukemia · doi:10.1038/s41375-021-01382-3 · Cited by 92
Clonal hematopoiesis of indeterminate potential is associated with acute kidney injury
Vlasschaert, C., Robinson‐Cohen, C., Chen, J., Akwo, E. A., Parker, A., Silver, S. A., Bhatraju, P. K., Poisner, H. M., Cao, S., Jiang, M., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02854-6 · Cited by 110
Self-citationAn Important Role for DNMT3A-Mediated DNA Methylation in Cardiomyocyte Metabolism and Contractility
Madsen, A., Höppner, G., Krause, J., Hirt, M. N., Laufer, S. D., Schweizer, M., Tan, W. L. W., Mosqueira, D., Anene-Nzelu, C. G., Lim, I. Y., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044444 · Cited by 96
Dholaria, B., Savani, B. N., Hamilton, B. K., Oran, B., Liu, H. D., Tallman, M. S., Ciurea, S. O., Holtzman, N. G., Phillips, G. L., Devine, S. M., et al. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2020.09.020 · Cited by 98
Nakao, T., Bick, A. G., Taub, M. A., Zekavat, S. M., Uddin, M. M., Niroula, A., Carty, C. L., Lane, J., Honigberg, M. C., Weinstock, J. S., et al. (2022) · Science Advances · doi:10.1126/sciadv.abl6579 · Cited by 94
“%) individuals had variant allele frequency (VAF) greater than 0.10, a threshold previously associated with increased CAD incidence (table S1) ( 23 , 24 , 26 ).”
InfluentialSelf-citationCobo, I., Tanaka, T. N., Glass, C. K., & Yeang, C. (2021) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000688 · Cited by 95
“CHIP with a VAF of as little as 10% was sufficiently associated with ASCVD risk [65].”
BackgroundSleep exerts lasting effects on hematopoietic stem cell function and diversity
McAlpine, C. S., Kiss, M. G., Zuraikat, F. M., Cheek, D. M., Schiroli, G., Amatullah, H., Huynh, P., Bhatti, M. Z., Wong, L. P., Yates, A. G., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20220081 · Cited by 97
“CH is associated with accelerated epigenetic aging of HSPCs (Nachun et al., 2021), a twofold increased clinical risk of CVDs (Jaiswal et al., 2017), and all-cause mortality (Jaiswal et al., 2014).”
BackgroundTargeting inflammation to reduce recurrent stroke
Zietz, A., Gorey, S., Kelly, P. J., Mira, K., & McCabe, J. J. (2023) · International Journal of Stroke · doi:10.1177/17474930231207777 · Cited by 96
“52 CHIP is believed to enhance vascular risk by priming monocytes to release excessive inflammatory cytokines.”
BackgroundEpidermal Tissue Adapts to Restrain Progenitors Carrying Clonal p53 Mutations
Murai, K., Skrupskelyte, G., Piedrafita, G., Hall, M., Kostiou, V., Ong, S. H., Nagy, T., Cagan, A., Goulding, D., Klein, A. M., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.08.017 · Cited by 85
“Proliferating human tissues harbor substantial populations of stem/progenitor cells carrying somatic mutations linked to neoplasia and other diseases (Alexandrov et al., 2015; Jaiswal et al., 2017).”
BackgroundClonal hematopoiesis in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis
Arends, C. M., Weiss, M., Christen, F., Eulenberg-Gustavus, C., Rousselle, A., Kettritz, R., Eckardt, K.-U., Chan, W., Hoyer, K., Frick, M., et al. (2020) · Haematologica · doi:10.3324/haematol.2019.223305 · Cited by 86
“4%), a significantly higher prevalence than reported in healthy cohorts and in our age-matched control group, but comparable to increased frequencies reported in patients with cancer,(12) aplastic anemia(18) and cardiovascular disease.(5) While altered inflammatory signaling has been proposed as a mechanism underlying…”
Innate and adaptive immunity: the understudied driving force of heart valve disease
Bartoli-Leonard, F., Zimmer, J., & Aikawa, E. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab273 · Cited by 81
“Unexpectedly, CHIP has been strongly associated with cardiovascular mortality and increased of coronary artery disease and progression of mineralization, with carriers four times more likely to experience myocardial infarction than non-carriers.(163,164) Unassociated to traditional cardiovascular risk factors, recent…”
BackgroundT Cell Immunosenescence in Aging, Obesity, and Cardiovascular Disease
Shirakawa, K., & Sano, M. (2021) · Cells · doi:10.3390/cells10092435 · Cited by 98
“It has been reported that a certain percentage of hematopoietic stem/progenitor cells with a specific genetic mutation called clonal hematopoiesis of indeterminate potential (CHIP) appear in the elderly, which is not only associated with the risk of hematopoietic tumors but also with the development of atherosclerotic…”
BackgroundClonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD
Khetarpal, S. A., Qamar, A., Bick, A. G., Fuster, J. J., Kathiresan, S., Jaiswal, S., & Natarajan, P. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.05.045 · Cited by 84
Self-citationDemaree, B., Delley, C. L., Vasudevan, H. N., Peretz, C. A. C., Ruff, D., Smith, C. C., & Abate, A. R. (2021) · Nature Communications · doi:10.1038/s41467-021-21810-3 · Cited by 83
Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged ≥80 years
van Zeventer, I. A., Salzbrunn, J. B., de Graaf, A. O., van der Reijden, B. A., Boezen, H. M., Vonk, J. M., van der Harst, P., Schuringa, J. J., Jansen, J. H., & Huls, G. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020004062 · Cited by 83
The AIM2 inflammasome: A novel biomarker and target in cardiovascular disease
Du, L., Wang, X., Chen, S., & Guo, X. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106533 · Cited by 95
Vlasschaert, C., Heimlich, J. B., Rauh, M. J., Natarajan, P., & Bick, A. G. (2023) · Circulation · doi:10.1161/circulationaha.122.062126 · Cited by 91
Self-citationGenetic modification of inflammation- and clonal hematopoiesis–associated cardiovascular risk
Yu, Z., Fidler, T. P., Ruan, Y., Vlasschaert, C., Nakao, T., Uddin, M. M., Mack, T., Niroula, A., Heimlich, J. B., Zekavat, S. M., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci168597 · Cited by 83
“We examined pairs of common CHIP mutations that are associated with CVD risk (6), including DNMT3A, TET2, ASXL1, and JAK2, and genetically predicted expression levels of inflammatory genes that are biologically closely related to the NLRP3 or AIM2 inflammasomes; these genes were selected based on established biologica…”
BackgroundMethodSelf-citationNormal Hematopoiesis Is a Balancing Act of Self-Renewal and Regeneration
Olson, O. C., Kang, Y.-A., & Passegué, E. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a035519 · Cited by 76
Yura, Y., Miura-Yura, E., Katanasaka, Y., Min, K.-D., Chavkin, N., Polizio, A. H., Ogawa, H., Horitani, K., Doviak, H., Evans, M. A., et al. (2021) · Circulation Research · doi:10.1161/circresaha.121.319314 · Cited by 87
Cardiovascular Disease and Cancer: Is There Increasing Overlap?
Vincent, L. L., Leedy, D. J., Masri, S. C., & Cheng, R. K.-H. (2019) · Current Oncology Reports · doi:10.1007/s11912-019-0796-0 · Cited by 91
Clinical approach to the inflammatory etiology of cardiovascular diseases
Ruscica, M., Corsini, A., Ferri, N., Banach, M., & Sirtori, C. R. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104916 · Cited by 89
Managing Clonal Hematopoiesis in Patients With Solid Tumors
Bolton, K. L., Gillis, N. K., Coombs, C. C., Takahashi, K., Zehir, A., Bejar, R., Garcia-Manero, G., Futreal, A., Jensen, B. C., Diaz, L. A., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.00331 · Cited by 87
“001).(9,10) In these studies, the strength of the association between CH and CVD was comparable to well-validated traditional cardiovascular risk factors such as high cholesterol, smoking, and hypertension.”
BackgroundResultImmunometabolic function of cholesterol in cardiovascular disease and beyond
Yvan‐Charvet, L., Bonacina, F., Guinamard, R., & Norata, G. D. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz127 · Cited by 91
“Clonal haematopoiesis, which leads to chronic low-grade inflammation and the activation of the inflammasome,(149,150) has also emerged as an independent risk of atherosclerotic CVD with a prevalence of 2–3% in the ageing population.(150) These aspects further support the need of addressing in the experimental as well…”
BackgroundBusque, L., Sun, M., Buscarlet, M., Ayachi, S., Feroz Zada, Y., Provost, S., Bourgoin, V., Mollica, L., Meisel, M., Hinterleitner, R., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000770 · Cited by 87
“60 years old and confers an increased risk of progression to hematological cancers and cardiovascular diseases.(5,6,8,9) The precise risk associated with the presence of CH in healthy individuals is uncertain; hence, the creation of a clinical entity named clonal hematopoiesis of indeterminate potential (CHIP).”
BackgroundSano, S., Wang, Y., Ogawa, H., Horitani, K., Sano, M., Polizio, A. H., Kour, A., Yura, Y., Doviak, H., & Walsh, K. (2021) · JCI Insight · doi:10.1172/jci.insight.146076 · Cited by 79
Interplay between periodontitis and chronic kidney disease
Chapple, I., Hirschfeld, J., Cockwell, P., Dietrich, T., & Sharma, P. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00910-5 · Cited by 98
“Although associated originally with myelodysplasia and acute myeloid leukaemia, CHIP was shown to contribute to coronary artery disease in mice, via accelerated atherosclerosis 99 .”
Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment
Comen, E. A., Bowman, R. L., & Kleppe, M. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00056 · Cited by 99
Lopez‐Mattei, J., Yang, E. H., Baldassarre, L. A., Agha, A. M., Blankstein, R., Choi, A., Chen, M. Y., Meyersohn, N. M., Daly, R. P., Slim, A. M., et al. (2022) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2022.09.002 · Cited by 88
The Role of Endothelial Cells in Atherosclerosis
Pepin, M. E., & Gupta, R. M. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.09.012 · Cited by 91
“24 ECs also directly secrete IL-1b and other atherosclerosis-inducing cytokines such as monocyte chemoattractant protein-1 (MCP-1) and IL-8.”
BackgroundGermline risk of clonal haematopoiesis
Silver, A. J., Bick, A. G., & Savona, M. R. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00356-6 · Cited by 82
Self-citationRauch, P. J., Gopakumar, J., Silver, A. J., Nachun, D. C., Ahmad, H., McConkey, M. E., Nakao, T., Bosse, M. M., Rentz, T., Gonzalez, N. V., et al. (2023) · Nature Cardiovascular Research · doi:10.1038/s44161-023-00326-7 · Cited by 130
Self-citationClonal Hematopoiesis and Incident Heart Failure With Preserved Ejection Fraction
Schuermans, A., Honigberg, M. C., Raffield, L. M., Yu, B., Roberts, M. B., Kooperberg, C. L., Desai, P. M., Carson, A. P., Shah, A. M., Ballantyne, C. M., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.53244 · Cited by 92
Self-citationInflammatory bone marrow microenvironment
Leimkühler, N. B., & Schneider, R. K. (2019) · Hematology · doi:10.1182/hematology.2019000045 · Cited by 82
“These findings are supported by recent findings demonstrating a causal link between mutations in HSPCs in the context of clonal hematopoiesis with indeterminate origin and altered transcriptional output of macrophages, which affect the vascular wall and contributes to atherosclerosis.(83,84) Furthermore, inflammation…”
ResultGreenfield, G., McPherson, S., Mills, K., & McMullin, M. F. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1729-7 · Cited by 89
Winter, S., Shoaie, S., Kordasti, S. Y., & Platzbecker, U. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.01823 · Cited by 88
Neutrophils in cardiovascular disease: warmongers, peacemakers, or both?
Sreejit, G., Johnson, J., Jaggers, R. M., Dahdah, A., Murphy, A. J., Hanssen, N. M. J., & Nagareddy, P. R. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab302 · Cited by 90
González, A., Richards, M., de Boer, R. A., Thum, T., Arfsten, H., Hülsmann, M., Falcão‐Pires, I., Díez, J., Foo, R., Chan, M. Y., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2493 · Cited by 86
Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incident Type 2 Diabetes Risk
Tobias, D. K., Manning, A. K., Wessel, J., Raghavan, S., Westerman, K. E., Bick, A. G., DICORPO, D. A., Whitsel, E. A., Collins, J. M., Correa, A., et al. (2023) · Diabetes Care · doi:10.2337/dc23-0805 · Cited by 90
Self-citationHematopoietic stem cell aging and leukemia transformation
Díaz, P. A. C., Mistry, J. J., & Trowbridge, J. J. (2023) · Blood · doi:10.1182/blood.2022017933 · Cited by 87
“CH has been associated with an increased risk of nonhematologic diseases, such as atherosclerosis 34 and osteoporosis.”
Loss of TET2 in human hematopoietic stem cells alters the development and function of neutrophils
Huerga Encabo, H., Aramburu, I. V., Garcia-Albornoz, M., Piganeau, M., Wood, H., Song, A., Ferrelli, A., Sharma, A., Minutti, C. M., Domart, M.-C., et al. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.05.004 · Cited by 81
RUNX1 Mutations in Inherited and Sporadic Leukemia
Bellissimo, D. C., & Speck, N. A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00111 · Cited by 84
“…cell specific disruption of Tet2 with Lyz2-Cre elevated mRNAs encoding multiple chemokines and inflammatory cytokines; furthermore, endotoxin stimulation of Tet2 deficient macrophages resulted in more robust secretion of IL-1β and IL-6 (Cull et al., 2017; Fuster et al., 2017; Jaiswal et al., 2017).”
BackgroundInfluentialBoettcher, S., Wilk, C. M., Singer, J., Beier, F., Burcklen, E., Beisel, C., Ventura Ferreira, M. S., Gourri, E., Gassner, C., Frey, B. M., et al. (2020) · Blood · doi:10.1182/blood.2019003079 · Cited by 81
Self-citationClonal hematopoiesis and inflammation – the perpetual cycle
Avagyan, S., & Zon, L. I. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.12.001 · Cited by 79
Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms
Oyarzún, C. P. M., & Heller, P. G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01373 · Cited by 82
“Interestingly, individuals harboring JAK2V617F-positive clonal hematopoiesis of indeterminate potential, in the absence of overt MPN, have an increased thrombotic risk, highlighting the relevance of the JAK2mutation in the thrombotic predisposition (11, 12).”
BackgroundAnzai, A., Ko, S., & Fukuda, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095214 · Cited by 88
“Interestingly, while circulating leukocyte counts remain unchanged, Tet2-deficient monocytes dominate in the blood over time [98,99].”
BackgroundWang, P., Song, Q., Ren, J., Zhang, W., Wang, Y., Zhou, L., Wang, D., Chen, K., Jiang, L., Zhang, B., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abp8704 · Cited by 89
Concise Review: Age-Related Clonal Hematopoiesis: Stem Cells Tempting the Devil
Busque, L., Buscarlet, M., Mollica, L., & Levine, R. L. (2018) · Stem Cells · doi:10.1002/stem.2845 · Cited by 78
Ferrone, C. K., Blydt-Hansen, M., & Rauh, M. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020626 · Cited by 74
“The involvement of hematological TET2-deficiency in the pathogenesis of atherosclerosis has been investigated at the cellular level [57,61].”
BackgroundInfluentialBellissimo, D. C., Chen, C.-H., Zhu, Q., Bagga, S., Lee, C.-T., He, B., Wertheim, G. B. W., Jordan, M. S., Tan, K., Worthen, G. S., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000785 · Cited by 83
“The most significant clinical consequence of CHIP is increased death due to cardiovascular events,(30,34) which murine models directly linked to dysregulated inflammation in macrophages with TET2 loss.(29,30) The parallel inflammatory phenotypes of RUNX1 and TET2 loss suggest”
BackgroundRole of neutrophils in different stages of atherosclerosis
Zhang, X., Kang, Z., Yin, D., & Gao, J. (2023) · Innate Immunity · doi:10.1177/17534259231189195 · Cited by 91
“mutation imparts a greater risk of premature myocardial infarction, stroke, and clonal hematopoiesis of indeterminate potential and exacerbated atherosclerosis via the AIM2 inflammasome.(122,123) Deleting critical inflammasome components, such as caspase 1 and 11, gasdermin D or inhibiting IL-1β reduces necrotic core…”
Insights from thrombi retrieved in stroke due to large vessel occlusion
Bacigaluppi, M., Semerano, A., Gullotta, G. S., & Strambo, D. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19856131 · Cited by 77
Cellular cross-talks in the diseased and aging heart
Wagner, J. U. G., & Dimmeler, S. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.11.152 · Cited by 84
Aging Fits the Disease Criteria of the International Classification of Diseases
Khaltourina, D. A., Matveyev, Y., Alekseev, A., Cortese, F., & Ioviţă, A. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111230 · Cited by 85
Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction
Cochran, J. D., Yura, Y., Thel, M. C., Doviak, H., Polizio, A. H., Arai, Y., Arai, Y., Horitani, K., Park, E., Chavkin, N. W., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.064170 · Cited by 84
“6,7 In this process, hematopoietic stem cells (HSCs) incur somatic mutations as a consequence of aging, smoking, or other environmental or biological stresses.”
Pervizaj-Oruqaj, L., Ferrero, M. R., Matt, U., & Herold, S. (2024) · European Respiratory Review · doi:10.1183/16000617.0263-2023 · Cited by 82
“CHIP contributes to the altered inflammatory response seen in chronic diseases related to inflammatory macrophage phenotypes, including cardiovascular disease [165], COPD, IPF [162, 166, 167] and atherosclerosis [168].”
BackgroundClonal hematopoiesis and atherosclerosis
Oren, O., Small, A. M., & Libby, P. (2024) · Journal of Clinical Investigation · doi:10.1172/jci180066 · Cited by 82
“Activation of the NLRP3 inflammasome, with increases in systemic IL-1 β , IL-6, IL-8.”
BackgroundResultInfluentialSelf-citationCardiovascular Considerations After Cancer Therapy
Blaes, A. H., Nohria, A., Armenian, S. H., Bergom, C. R., Thavendiranathan, P., Barac, A., Sanchez‐Petitto, G., Desai, S., Zullig, L. L., Morgans, A. K., et al. (2025) · JACC CardioOncology · doi:10.1016/j.jaccao.2024.06.006 · Cited by 100
Shumliakivska, M., Luxán, G., Hemmerling, I., Scheller, M., Li, X., Müller-Tidow, C., Schuhmacher, B., Sun, Z., Dendorfer, A., Debes, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-43003-w · Cited by 76
“…as clinical single-cell RNA sequencing studies have revealed that DNMT3A and TET2 CHIP-driver mutations in fl uence the in fl ammatory potential of circulating immune cells, potentially contributing to the promotion of diffuse cardiac fi brosis and consequently impacting long-term outcome 4,12 – 16 .”
EASIX for prediction of survival in lower-risk myelodysplastic syndromes
Merz, A. M. A., Germing, U., Kobbe, G., Kaivers, J., Jauch, A. S., Radujkovic, A., Hummel, M., Benner, A., Merz, M., Dreger, P., et al. (2019) · Blood Cancer Journal · doi:10.1038/s41408-019-0247-z · Cited by 82
Clinical insights into the origins of thrombosis in myeloproliferative neoplasms
Moliterno, A. R., Ginzburg, Y. Z., & Hoffman, R. (2020) · Blood · doi:10.1182/blood.2020008043 · Cited by 81
Leisch, M., Jansko, B., Zaborsky, N., Greil, R., & Pleyer, L. (2019) · Cancers · doi:10.3390/cancers11020252 · Cited by 82
“Individuals with CHIP harbor a higher risk for development of a myeloid neoplasm (about 1% per year), but also have for example a two fold higher risk for the development coronary heart disease [11].”
BackgroundWu, Z., Gao, S., Gao, Q., Patel, B. A., Groarke, E. M., Feng, X., Manley, A. L., Li, H., Cardona, D. O., Kajigaya, S., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101160 · Cited by 84
“Somatic mutations may also contribute to other complex multifactorial processes such as atherosclerosis and clonal hematopoiesis of indeterminate potential (CHIP).(23) VEXAS is an example of a non-malignant disease secondary to acquired mutations.”
BackgroundEnvironmental influences on clonal hematopoiesis
King, K. Y., Huang, Y., Nakada, D., & Goodell, M. A. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2019.12.005 · Cited by 73
“Not only are individuals with CH at significantly greater risk of developing hematologic malignancies compared to their non-CH counterparts, but importantly they have greater all-cause mortality largely from heart disease and stroke (Jaiswal et al., 2014; Jaiswal et al., 2017).”
BackgroundHow, J., & Hobbs, G. S. (2020) · Cancers · doi:10.3390/cancers12071954 · Cited by 77
Epigenetic Regulation of Vascular Diseases
Zarzour, A., Kim, H. W., & Weintraub, N. L. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.312193 · Cited by 81
“A more recent study has confirmed the existence of independent associations between mutations in each of these 3 genes and coronary artery disease, with median variant allele fraction ranging from 10% to 20%.(44) Moreover, studies in animal models of clonal hematopoiesis of indeterminate potential, in which TET2 mutan…”
BackgroundHigh frequency of clonal hematopoiesis in Erdheim-Chester disease
Aubart, F. C., Roos‐Weil, D., Armand, M., Marceau‐Renaut, A., Emile, J., Duployez, N., Charlotte, F., Poulain, S., Lhote, R., Hélias‐Rodzewicz, Z., et al. (2020) · Blood · doi:10.1182/blood.2020005101 · Cited by 78
Knudsen, T. A., Skov, V., Stevenson, K. E., Werner, L. L., Duke, W., Laurore, C., Gibson, C. J., Nag, A., Thorner, A. R., Wollison, B. M., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2021004856 · Cited by 80
“Age, median (range), y 68 (60-80) 60 (21-88) 58 (20-81) 62 (20-88)”
Self-citation
Metadata
- Authors
- Jaiswal, S., Natarajan, P., Silver, A. J., Gibson, C. J., Bick, A. G., Shvartz, E., McConkey, M., Gupta, N., Gabriel, S., Ardissino, D., Baber, U., Mehran, R., Fuster, V., Danesh, J., Frossard, P., Saleheen, D., Melander, O., Sukhova, G. K., Neuberg, D., Libby, P., Kathiresan, S., & Ebert, B. L.
- Affiliations
- Brigham and Women's Hospital (US)
- Broad Institute (US)
- ORCID
- Jaiswal, Siddhartha
- Natarajan, Pradeep
- Silver, Alexander J.
- Gibson, Christopher J.
- Bick, Alexander G.
- McConkey, Marie
- Gupta, Namrata
- Gabriel, Stacey
- Ardissino, Diego
- Baber, Usman
- Mehran, Roxana
- Danesh, John
- Saleheen, Danish
- Melander, Olle
- Sukhova, Galina K.
- Neuberg, Donna
- Libby, Peter
- Kathiresan, Sekar
- Ebert, Benjamin L.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2017-07-13
- Volume
- 377
- Issue
- 2
- Pages
- 111-121
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC6717509
- OpenAlex
- W2628145035
- Cited by
- 2,683
- References
- 37
- Citations by year
- 2026: 303 · 2025: 322 · 2024: 347 · 2023: 338 · 2022: 371 · 2021: 303 · 2020: 263 · 2019: 215 · 2018: 169 · 2017: 44
- FWCI
- 143.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Apollo
- Funders
- Wellcome Trust
- National Institute for Health and Care Research (NF-SI-0512-10165)
- British Heart Foundation (RG/08/014/24067)
- Novo Nordisk Fonden (NNF14OC0009819, NNF13OC0005339)
- Medical Research Council (MR/L003120/1)
- National Heart, Lung, and Blood Institute (R01HL082945, R01HL080472, RC2HL101834, T32HL116324)
- National Human Genome Research Institute (U54HG003067)
- Fogarty International Center (RC1TW008485)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- clonal hematopoiesis of indeterminate potential, atherosclerotic cardiovascular disease, coronary artery disease, myocardial infarction, coronary artery calcification, TET2 mutation, DNMT3A, ASXL1, JAK2, somatic mutations, atherosclerosis, cytokines and chemokines, macrophages, bone marrow transplantation
- MeSH terms
- Animals, Coronary Disease, Hematopoiesis, Hematopoietic Stem Cells, Humans, Mutation, Risk, Case-Control Studies, Sequence Analysis, DNA, Mice, Knockout, Genetic Predisposition to Disease, Atherosclerosis, Mice, Exome, Clonal Evolution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.